Clinical Trial Update: Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 study of AU-011 (Belzupacap Sarotalocan) delivered suprachoroidally in subjects with primary indeterminate lesions and small choroidal melanoma has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Melanoma
• Uveal Melanoma

Drugs mentioned

• AU-011 (Belzupacap Sarotalocan)

Snippet

Sponsor: Aura Biosciences | Conditions: Uveal Melanoma, Ocular Melanoma | Phase 2 | Status: COMPLETED